Cited by 32Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchAdvanced Glycation End Products research

Glycated albumin and risk of mortality in the US adult population

Open access
Rooney, Mary R, Daya, Natalie, Tang, Olive, McEvoy, John William, Coresh, Josef, Christenson, Robert H, Selvin, Elizabeth·2022·Clinical Chemistry

Abstract

Background: Glycated albumin is of growing interest as an alternative biomarker of glycemia. However, the association of glycated albumin with long-term outcomes in the general population is uncharacterized. We evaluated the associations of glycated albumin and hemoglobin A1c (HbA1c) with mortality in US adults. Methods: We conducted a prospective analysis of 12 915 participants in the National Health and Nutrition Examination Survey 1999–2004. We used Cox regression to characterize associations of glycated albumin and HbA1c with all-cause and cardiovascular mortality through 2014. We categorized glycated albumin based on percentiles corresponding to clinical cut-points for HbA1c. No diagnosed diabetes: <5.0% (<12th percentile), 5.0% to 5.6% (12th–82nd percentile, reference), 5.7% to 6.4% (83rd–97th percentile), and ≥6.5% (≥98th percentile). Diagnosed diabetes: <7.0% (<50th percentile), 7.0% to 8.9% (50th–83rd percentile), and ≥9.0% (≥84th percentile). Results: Among US adults (mean age 46 years), the prevalence of diagnosed diabetes was 6.8%. Glycated albumin and HbA1c were highly correlated (r = 0.76). Over the median 16.8 years follow-up, there were 2818 deaths (652 cardiovascular). Adults with diagnosed diabetes and glycated albumin ≥84th percentile had the highest risk for all-cause mortality [hazard ratio (HR) 3.96, 95% CI 3.06–5.13] and cardiovascular mortality (HR 6.80, 95% CI 4.20–11.03). HbA1c had associations with all-cause and cardiovascular mortality that were similar to those for glycated albumin. Conclusions: Among US adults, increased values of glycated albumin and HbA1c were associated with all-cause and cardiovascular mortality, particularly in persons with diagnosed diabetes. Glycated albumin may be a useful alternative test of glycemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/clinchem/hvab232

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fructosamine and glycated albumin have been linked to long-term complications in epidemiologic cohort studies.

    “Fructosamine and glycated albumin have been linked to long-term complications in epidemiologic cohort studies (14)(15)(16)(17)(18).”

    From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [15]

    The Discussion reports that glycated albumin was associated with mortality in this study and with microvascular and cardiovascular outcomes in earlier cohort work. The References name cohort studies of both fructosamine and glycated albumin, but this paper does not itself report a fructosamine–complications association; that part rests on the cited studies’ titles. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rooney, M. R., Daya, N., Tang, O., McEvoy, J. W., Coresh, J., Christenson, R. H., & Selvin, E.
Affiliations
  • Johns Hopkins University (US)
  • Ollscoil na Gaillimhe – University of Galway (IE)
  • University of Maryland, Baltimore (US)
Corresponding author
Selvin, Elizabeth
Venue
Clinical Chemistry
Published
2022-01-29
Volume
68
Issue
3
Pages
422-430
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W4205588773
Cited by
32
References
40
Citations by year
2026: 5 · 2025: 6 · 2024: 8 · 2023: 6 · 2022: 5 · 2021: 2
FWCI
3.91
Type
journal article
Language
en
Open access
Locations
  • Clinical Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Biomarkers Consortium of the Foundation for the National Institutes of Health and NIH/NHLBI (K24 HL152440, T32 HL007024)
  • NIH/NIDDK (F30 DK120160)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
glycated albumin, HbA1c, glycemic markers, mortality, cardiovascular mortality, all-cause mortality, diabetes mellitus, glycemia, NHANES
MeSH terms
Glycated Serum Albumin, Adult, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Glycated Hemoglobin, Humans, Middle Aged, Nutrition Surveys, Risk Factors, Serum Albumin, Glycation End Products, Advanced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review